Lichen Sclerosus


(LSetA) (Figure 3.37C)
  • Autoimmune disease occurring in children and women in the 5 th or 6 th decade (less often in men)
  • Autoantibody likely to extracellular matrix protein-1 (ECM-1)
  • Presents initially as pruritic hypopigmented plaques typically with pink inflammatory border most commonly in genital area; expands and becomes atrophic, ± follicular hyperkeratosis; figure-of-eight pattern if perianal/vulvar area involved; dyspareunia, difficulty urinating, scarring/ contractures (if advanced), ↑ risk of SCC in sclerotic areas

  •    
     
    Five percent lifetime risk of SCC
     
       

  • Histology: atrophic epidermis, ± follicular plugging, vacuolar degeneration at basal layer, band-like lymphocytic infiltrate, pale staining homogenized collagen with edema (± subepidermal bulla), dilated lymphatic vessels
  • Treatment: superpotent topical corticosteroid
  • Associated with other autoimmune diseases (i.e. thyroid disease, pernicious anemia)

Figure 3.37 A: Telangiectasias in CREST (Courtesy of Dr. Paul Getz) B: Relapsing polychondritis (Reprint from Morgan MB, Smoller BR, Somach SC. Deadly Dermatologic Diseases. New York, NY: Springer; 2007) C: Lichen sclerosus (Courtesy of Dr. Iris K. Aronson)
Figure 3.37
A: Telangiectasias in CREST
(Courtesy of Dr. Paul Getz)
B: Relapsing polychondritis
(Reprint from Morgan MB,
Smoller BR, Somach SC.
Deadly Dermatologic Diseases.
New York, NY: Springer; 2007
)
C: Lichen sclerosus
(Courtesy of Dr. Iris K.
Aronson
)